ASHLEIGH MELVIN: Open Payments
NPI 1801247945 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 29 payments from 9 companies in 2025. Trend: 2023 $160 · 2024 $338 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $238 |
| Novo Nordisk Inc | 8 | $148 |
| Abbott Laboratories | 2 | $50 |
| Exact Sciences Corporation | 3 | $47 |
| PFIZER INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, Wegovy, Cologuard Collection Kit, Ozempic, NURTEC ODT, Rybelsus, REXULTI.
Industry payments across MS — which companies pay providers there.
